These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5264481)

  • 1. [The dynamics of pyrocatechin content of the myocardium and blood in experimental atherosclerosis and coronary insufficiency caused by limitation of the mobility in rabbits].
    Tiavokin VV; Prokopovich NB
    Patol Fiziol Eksp Ter; 1968; 12(2):63-4. PubMed ID: 5264481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood sugar concentration dynamics in experimental atherosclerosis and coronary insufficiency caused by limitation of movement in rabbits].
    Tiavokin VV
    Biull Eksp Biol Med; 1968 Dec; 66(12):27-8. PubMed ID: 5742303
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the characteristics of myocardial glycogen in the rabbit in normal state and in experimental arteriosclerosis].
    Repetun NI
    Arkh Anat Gistol Embriol; 1967 Aug; 53(8):81-3. PubMed ID: 5603362
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some indices of metabolic processes in rabbit cerebral hemispheres in experimental atherosclerosis].
    Pogodaev KI; Turova NF
    Ukr Biokhim Zh; 1967; 39(1):29-33. PubMed ID: 5603043
    [No Abstract]   [Full Text] [Related]  

  • 5. [A means of accelerated production of experimental atherosclerosis with coronary insufficiency].
    Tiavokin VV
    Patol Fiziol Eksp Ter; 1966; 10(1):77-8. PubMed ID: 5240493
    [No Abstract]   [Full Text] [Related]  

  • 6. [Catecholamine content in the endocrine glands and tissues of rabbits with experimental atherosclerosis].
    Kubli SKh
    Patol Fiziol Eksp Ter; 1965; 9(6):18-21. PubMed ID: 5873911
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzyme activities, energy phosphates and noradrenaline content in the isolated ischemic guinea pig myocardium].
    Moser K; Lujf A; Suko J
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 147(4):267-76. PubMed ID: 5670678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in myocardial norepinephrine and glycogen phosphorylase in ischemic and non-ischemic areas].
    Sakai K; Abiko Y
    Kokyu To Junkan; 1983 Jan; 31(1):15-8. PubMed ID: 6857010
    [No Abstract]   [Full Text] [Related]  

  • 9. Exaggerated nicotine-induced norepinephrine release from atherosclerotic rabbit hearts.
    Gillespie MN; Owasoyo JO; Kiritsy-Roy JA; O'Connor WN; Van Loon GR
    Toxicology; 1985 Oct; 37(1-2):147-57. PubMed ID: 4060165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Energy formation processes in the myocardium during measured limitation of coronary blood flow].
    Frol'kis RA; Tsiomik VA; Likhtenshteĭn IE; Evstratova IN
    Vopr Med Khim; 1981; 27(1):47-51. PubMed ID: 6258321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoperoxidative damage in experimental rabbits with atherosclerosis.
    Chen Y; Zhou M; Kong H
    Chin Med J (Engl); 1993 Feb; 106(2):110-4. PubMed ID: 8504693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinin system of the blood and myocardium in monitored limitation of the coronary blood flow].
    Gunina LM
    Vopr Med Khim; 1981; 27(5):630-3. PubMed ID: 6171933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipolytic activity of the heart muscle and the aorta in experimental cholesterol atherosclerosis.
    Szabó R; Benkö S; Szarvas F; Varga L
    Cor Vasa; 1970; 12(1):57-64. PubMed ID: 5446027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oxidative processes in the myocardium in limited coronary blood flow].
    Frol'kis RA; Likhtenshteĭn IE; Evstratova IN; Kuznetsova OA; Drachenko VP
    Vrach Delo; 1987 Sep; (9):13-5. PubMed ID: 3424761
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of disturbances in the deamination of nitrogenous compounds in experimental hypercholesterolemia and atherosclerosis].
    Khuzhamberdiev M; Mamadiev M; Gorkin VZ
    Vopr Med Khim; 1981; 27(6):829-35. PubMed ID: 7336659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidated and reduced nicotinamide coenzyme and -glycerophosphate in myocardium and aorta in experimental arteriosclerosis].
    Gil'miiarova FN; Tenisheva ZKh
    Ukr Biokhim Zh; 1971; 43(3):292-4. PubMed ID: 4342695
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes of protein metabolism in experimental atherosclerosis].
    Antov GP; Parlapanova M; Kazakova B; Aianova A
    Vopr Med Khim; 1982; 28(5):40-4. PubMed ID: 7179832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis supporting the primary role of increased platelet activity in atherosclerosis and coronary heart disease.
    Rees BW
    Med Lab Sci; 1987 Jul; 44(3):267-71. PubMed ID: 3323762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Disorders of glucide metabolism in atherosclerosis (coronary disease, degenerative arteriopathy of the lower extremities)].
    Jouve A; Gérard R; Vague P; Gaymard PJ
    Bull Mem Soc Med Hop Paris; 1965 Oct; 116(13):Suppl:1323-39. PubMed ID: 5859605
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac adrenergic mechanisms in rabbits with experimentally produced coronary atherosclerosis.
    Gillis RA; Melville KI
    Atherosclerosis; 1972; 15(1):71-6. PubMed ID: 5013278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.